A novel role for caveolin-1 in regulating endothelial nitric oxide synthase activation in response to H2O2 and shear stress

Free Radical Biology and Medicine

Volumn 49, Issue 2, 2010, Pages 159-170

  Tian, Jing ^a   Hou, Yali ^a   Lu, Qing ^a   Wiseman, Dean A ^a   Vasconcelos Fonsesca, Fabio ^a   Elms, Shawn ^a   Fulton, David J ^a   Black, Stephen M ^a  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

Free radicals; Gene expression; Oxidative stress; Protein trafficking

Indexed keywords

CALCIUM; CAVEOLIN 1; ENDOTHELIAL NITRIC OXIDE SYNTHASE; HYDROGEN PEROXIDE; NITRIC OXIDE; SMALL INTERFERING RNA;

ANIMAL CELL; ARTICLE; BINDING SITE; CELL MEMBRANE; CELL STRESS; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME LOCALIZATION; ENZYME REGULATION; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; SHEAR STRESS; SIGNAL TRANSDUCTION; VASCULAR ENDOTHELIUM;

ANIMALS; BINDING SITES; CATTLE; CAVEOLIN 1; CELL MEMBRANE; CERCOPITHECUS AETHIOPS; COS CELLS; ENDOTHELIUM, VASCULAR; ENZYME ACTIVATION; HYDROGEN PEROXIDE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE III; PROTEIN TRANSPORT; RNA, SMALL INTERFERING; SEQUENCE DELETION; SHEAR STRENGTH; SIGNAL TRANSDUCTION; TRANSGENES;

BOVINAE;

EID: 77953545003     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2010.03.023     Document Type: Article

References (61)

1. Arnal J.F., Dinh-Xuan A.T., Pueyo M., Darblade B., Rami J. Endothelium-derived nitric oxide and vascular physiology and pathology. Cell. Mol. Life Sci. 1999, 55:1078-1087.
2. Ignarro L.J., Buga G.M., Wood K.S., Byrns R.E., Chaudhuri G. Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide. Proc. Natl. Acad. Sci. U. S. A. 1987, 84:9265-9269.
3. Palmer R.M., Ferrige A.G., Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 1987, 327:524-526.
4. Cai H., Li Z., Davis M.E., Kanner W., Harrison D.G., Dudley S.C. Akt-dependent phosphorylation of serine 1179 and mitogen-activated protein kinase kinase/extracellular signal-regulated kinase 1/2 cooperatively mediate activation of the endothelial nitric-oxide synthase by hydrogen peroxide. Mol. Pharmacol. 2003, 63:325-331.
5. Thomas S.R., Chen K., Keaney J.F. Hydrogen peroxide activates endothelial nitric-oxide synthase through coordinated phosphorylation and dephosphorylation via a phosphoinositide 3-kinase-dependent signaling pathway. J. Biol. Chem. 2002, 277:6017-6024.
6. Drummond G.R., Cai H., Davis M.E., Ramasamy S., Harrison D.G. Transcriptional and posttranscriptional regulation of endothelial nitric oxide synthase expression by hydrogen peroxide. Circ. Res. 2000, 86:347-354.
7. 2+/calmodulin-dependent protein kinase II/janus kinase 2-dependent pathway. Arterioscler. Thromb. Vasc. Biol. 2001, 21:1571-1576.
8. Wedgwood S., Black S.M. Endothelin-1 decreases endothelial NOS expression and activity through ETA receptor-mediated generation of hydrogen peroxide. Am. J. Physiol. Lung Cell. Mol. Physiol. 2005, 288:L480-L487.
9. Kumar S., Sun X., Wedgwood S., Black S.M. Hydrogen peroxide decreases endothelial nitric oxide synthase promoter activity through the inhibition of AP-1 activity. Am. J. Physiol. Lung Cell. Mol. Physiol. 2008, 295:L370-L377.
10. Kumar S., Sun X., Wiseman D.A., Tian J., Umapathy N.S., Verin A.D., Black S.M. Hydrogen peroxide decreases endothelial nitric oxide synthase promoter activity through the inhibition of Sp1 activity. DNA Cell Biol. 2009, 28:119-129.
11. Oess S., Icking A., Fulton D., Govers R., Muller-Esterl W. Subcellular targeting and trafficking of nitric oxide synthases. Biochem. J. 2006, 396:401-409.
12. Shaul P.W. Regulation of endothelial nitric oxide synthase: location, location, location. Annu. Rev. Physiol. 2002, 64:749-774.
13. Garcia-Cardena G., Oh P., Liu J., Schnitzer J.E., Sessa W.C. Targeting of nitric oxide synthase to endothelial cell caveolae via palmitoylation: implications for nitric oxide signaling. Proc. Natl. Acad. Sci. U. S. A. 1996, 93:6448-6453.
14. Robinson L.J., Michel T. Mutagenesis of palmitoylation sites in endothelial nitric oxide synthase identifies a novel motif for dual acylation and subcellular targeting. Proc. Natl. Acad. Sci. U. S. A. 1995, 92:11776-11780.
15. Sakoda T., Hirata K., Kuroda R., Miki N., Suematsu M., Kawashima S., Yokoyama M. Myristoylation of endothelial cell nitric oxide synthase is important for extracellular release of nitric oxide. Mol. Cell. Biochem. 1995, 152:143-148.
16. Sessa W.C., Barber C.M., Lynch K.R. Mutation of N-myristoylation site converts endothelial cell nitric oxide synthase from a membrane to a cytosolic protein. Circ. Res. 1993, 72:921-924.
17. Davies P.F. Flow-mediated endothelial mechanotransduction. Physiol. Rev. 1995, 75:519-560.
18. Gimbrone M.A., Topper J.N., Nagel T., Anderson K.R., Garcia-Cardena G. Endothelial dysfunction, hemodynamic forces, and atherogenesis. Ann. N. Y. Acad. Sci. 2000, 902:230-239. discussion 239-240.
19. Boo Y.C., Jo H. Flow-dependent regulation of endothelial nitric oxide synthase: role of protein kinases. Am. J. Physiol. Cell Physiol. 2003, 285:C499-C508.
20. Lin M.C., Almus-Jacobs F., Chen H.H., Parry G.C., Mackman N., Shyy J.Y., Chien S. Shear stress induction of the tissue factor gene. J. Clin. Invest. 1997, 99:737-744.
21. Sud N., Sharma S., Wiseman D.A., Harmon C., Kumar S., Venema R.C., Fineman J.R., Black S.M. Nitric oxide and superoxide generation from endothelial NOS: modulation by HSP90. Am. J. Physiol. Lung Cell. Mol. Physiol. 2007, 293:L1444-L1453.
22. Sud N., Wells S.M., Sharma S., Wiseman D.A., Wilham J., Black S.M. Asymmetric dimethylarginine inhibits HSP90 activity in pulmonary arterial endothelial cells: role of mitochondrial dysfunction. Am. J. Physiol. Cell Physiol. 2008, 294:C1407-C1418.
23. Garcia-Cardena G., Martasek P., Masters B.S., Skidd P.M., Couet J., Li S., Lisanti M.P., Sessa W.C. Dissecting the interaction between nitric oxide synthase (NOS) and caveolin: functional significance of the NOS caveolin binding domain in vivo. J. Biol. Chem. 1997, 272:25437-25440.
24. Govers R., Rabelink T.J. Cellular regulation of endothelial nitric oxide synthase. Am. J. Physiol. Renal Physiol. 2001, 280:F193-F206.
25. Garcia-Cardena G., Fan R., Stern D.F., Liu J., Sessa W.C. Endothelial nitric oxide synthase is regulated by tyrosine phosphorylation and interacts with caveolin-1. J. Biol. Chem. 1996, 271:27237-27240.
26. 2+-calmodulin and caveolin. J. Biol. Chem. 1997, 272:15583-15586.
27. Feron O., Saldana F., Michel J.B., Michel T. The endothelial nitric-oxide synthase-caveolin regulatory cycle. J. Biol. Chem. 1998, 273:3125-3128.
28. Powers S.K., Jackson M.J. Exercise-induced oxidative stress: cellular mechanisms and impact on muscle force production. Physiol. Rev. 2008, 88:1243-1276.
29. Leung F.P., Yung L.M., Laher I., Yao X., Chen Z.Y., Huang Y. Exercise, vascular wall and cardiovascular diseases: an update (Part 1). Sports Med. 2008, 38:1009-1024.
30. Govers R., Bevers L., de Bree P., Rabelink T.J. Endothelial nitric oxide synthase activity is linked to its presence at cell-cell contacts. Biochem. J. 2002, 361:193-201.
31. Li J.M., Shah A.M. Endothelial cell superoxide generation: regulation and relevance for cardiovascular pathophysiology. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2004, 287:R1014-R1030.
32. Cai H. Hydrogen peroxide regulation of endothelial function: origins, mechanisms, and consequences. Cardiovasc. Res. 2005, 68:26-36.
33. Glenney J.R. Tyrosine phosphorylation of a 22-kDa protein is correlated with transformation by Rous sarcoma virus. J. Biol. Chem. 1989, 264:20163-20166.
34. Parton R.G., Simons K. The multiple faces of caveolae. Nat. Rev. Mol. Cell Biol. 2007, 8:185-194.
35. Williams T.M., Lisanti M.P. The caveolin genes: from cell biology to medicine. Ann. Med. 2004, 36:584-595.
36. Hernandez-Deviez D.J., Martin S., Laval S.H., Lo H.P., Cooper S.T., North K.N., Bushby K., Parton R.G. Aberrant dysferlin trafficking in cells lacking caveolin or expressing dystrophy mutants of caveolin-3. Hum. Mol. Genet. 2006, 15:129-142.
37. Wyse B.D., Prior I.A., Qian H., Morrow I.C., Nixon S., Muncke C., Kurzchalia T.V., Thomas W.G., Parton R.G., Hancock J.F. Caveolin interacts with the angiotensin II type 1 receptor during exocytic transport but not at the plasma membrane. J. Biol. Chem. 2003, 278:23738-23746.
38. Cohen A.W., Razani B., Wang X.B., Combs T.P., Williams T.M., Scherer P.E., Lisanti M.P. Caveolin-1-deficient mice show insulin resistance and defective insulin receptor protein expression in adipose tissue. Am. J. Physiol. Cell Physiol. 2003, 285:C222-C235.
39. 2+ influx channels by regulating plasma membrane localization of TRPC1. J. Biol. Chem. 2003, 278:27208-27215.
40. Maroto R., Raso A., Wood T.G., Kurosky A., Martinac B., Hamill O.P. TRPC1 forms the stretch-activated cation channel in vertebrate cells. Nat. Cell Biol. 2005, 7:179-185.
41. Minshall R.D., Sessa W.C., Stan R.V., Anderson R.G., Malik A.B. Caveolin regulation of endothelial function. Am. J. Physiol. Lung Cell Mol. Physiol. 2003, 285:L1179-L1183.
42. Anderson R.G. Caveolae: where incoming and outgoing messengers meet. Proc. Natl. Acad. Sci. U. S. A. 1993, 90:10909-10913.
43. Li S., Couet J., Lisanti M.P. Src tyrosine kinases, Galpha subunits, and H-Ras share a common membrane-anchored scaffolding protein, caveolin: caveolin binding negatively regulates the auto-activation of Src tyrosine kinases. J. Biol. Chem. 1996, 271:29182-29190.
44. Couet J., Li S., Okamoto T., Ikezu T., Lisanti M.P. Identification of peptide and protein ligands for the caveolin-scaffolding domain: implications for the interaction of caveolin with caveolae-associated proteins. J. Biol. Chem. 1997, 272:6525-6533.
45. Sbaa E., Frerart F., Feron O. The double regulation of endothelial nitric oxide synthase by caveolae and caveolin: a paradox solved through the study of angiogenesis. Trends Cardiovasc. Med. 2005, 15:157-162.
46. Feron O., Kelly R.A. The caveolar paradox: suppressing, inducing, and terminating eNOS signaling. Circ. Res. 2001, 88:129-131.
47. Drab M., Verkade P., Elger M., Kasper M., Lohn M., Lauterbach B., Menne J., Lindschau C., Mende F., Luft F.C., Schedl A., Haller H., Kurzchalia T.V. Loss of caveolae, vascular dysfunction, and pulmonary defects in caveolin-1 gene-disrupted mice. Science 2001, 293:2449-2452.
48. Shaul P.W., Smart E.J., Robinson L.J., German Z., Yuhanna I.S., Ying Y., Anderson R.G., Michel T. Acylation targets endothelial nitric-oxide synthase to plasmalemmal caveolae. J. Biol. Chem. 1996, 271:6518-6522.
49. Bauer P.M., Yu J., Chen Y., Hickey R., Bernatchez P.N., Looft-Wilson R., Huang Y., Giordano F., Stan R.V., Sessa W.C. Endothelial-specific expression of caveolin-1 impairs microvascular permeability and angiogenesis. Proc. Natl. Acad. Sci. U. S. A. 2005, 102:204-209.
50. Bucci M., Gratton J.P., Rudic R.D., Acevedo L., Roviezzo F., Cirino G., Sessa W.C. In vivo delivery of the caveolin-1 scaffolding domain inhibits nitric oxide synthesis and reduces inflammation. Nat. Med. 2000, 6:1362-1367.
51. Smart E.J., Graf G.A., McNiven M.A., Sessa W.C., Engelman J.A., Scherer P.E., Okamoto T., Lisanti M.P. Caveolins, liquid-ordered domains, and signal transduction. Mol. Cell. Biol. 1999, 19:7289-7304.
52. Ushio-Fukai M., Alexander R.W. Caveolin-dependent angiotensin II type 1 receptor signaling in vascular smooth muscle. Hypertension 2006, 48:797-803.
53. Blair A., Shaul P.W., Yuhanna I.S., Conrad P.A., Smart E.J. Oxidized low density lipoprotein displaces endothelial nitric-oxide synthase (eNOS) from plasmalemmal caveolae and impairs eNOS activation. J. Biol. Chem. 1999, 274:32512-32519.
54. - as well as EDHF in acetylcholine-induced relaxation depending on their relative contribution in different vascular beds. Life Sci. 2007, 80:1678-1685.
55. Monier S., Parton R.G., Vogel F., Behlke J., Henske A., Kurzchalia T.V. VIP21-caveolin, a membrane protein constituent of the caveolar coat, oligomerizes in vivo and in vitro. Mol. Biol. Cell 1995, 6:911-927.
56. Pol A., Martin S., Fernandez M.A., Ingelmo-Torres M., Ferguson C., Enrich C., Parton R.G. Cholesterol and fatty acids regulate dynamic caveolin trafficking through the Golgi complex and between the cell surface and lipid bodies. Mol. Biol. Cell 2005, 16:2091-2105.
57. Komers R., Schutzer W.E., Reed J.F., Lindsley J.N., Oyama T.T., Buck D.C., Mader S.L., Anderson S. Altered endothelial nitric oxide synthase targeting and conformation and caveolin-1 expression in the diabetic kidney. Diabetes 2006, 55:1651-1659.
58. Frank P.G., Lisanti M.P. Role of caveolin-1 in the regulation of the vascular shear stress response. J. Clin. Invest. 2006, 116:1222-1225.
59. Yu J., Bergaya S., Murata T., Alp I.F., Bauer M.P., Lin M.I., Drab M., Kurzchalia T.V., Stan R.V., Sessa W.C. Direct evidence for the role of caveolin-1 and caveolae in mechanotransduction and remodeling of blood vessels. J. Clin. Invest. 2006, 116:1284-1291.
60. Rizzo V., Morton C., DePaola N., Schnitzer J.E., Davies P.F. Recruitment of endothelial caveolae into mechanotransduction pathways by flow conditioning in vitro. Am. J. Physiol. Heart Circ. Physiol. 2003, 285:H1720-H1729.
61. Boyd N.L., Park H., Yi H., Boo Y.C., Sorescu G.P., Sykes M., Jo H. Chronic shear induces caveolae formation and alters ERK and Akt responses in endothelial cells. Am. J. Physiol. Heart Circ. Physiol. 2003, 285:H1113-H1122.